We could not find any results for:
Make sure your spelling is correct or try broadening your search.
RESEARCH TRIANGLE PARK, N.C., Oct. 11, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGND) today announced that it has regained compliance with the Nasdaq Global Market's $1.00 minimum bid price...
RESEARCH TRIANGLE PARK, N.C., Oct. 1, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGND) today provided an update on the status of the clinical development program for ICA-105665. As previously...
RESEARCH TRIANGLE PARK, N.C., Sept. 23, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGND) today announced an additional extension through December 2011 to an existing worldwide collaboration...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions